First General Meeting of the WHO-National Control Laboratory Network for Biologicals (WHO-NNB). Noida (India), 31 October – 2 November 2017
(2017; 15 pages)


The First General Meeting of the WHO Network for Biologicals (WHO-NNB - “the Network”) was held on 31 October – 2 November 2017 in Noida, India. The meeting was organized by WHO, Department of Essential Medicines and Health Products (EMP), Regulatory Systems Strengthening (RSS) hosted by the National Institute of Biologicals (NIB), Ministry of Health and Family Welfare, Government of India. Participants from 21 national control laboratories (NCLs), comprising 20 out of the 24 NCLs currently responsible for lot release and/or contracted for testing of WHO-prequalified vaccines attended the meeting. Furthermore the meeting was attended by representatives from two industry associations, namely the Developing Countries Vaccine Manufacturers Network (DCVMN) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), and a member of the European Directorate for the Quality of Medicines & HealthCare (EDQM) as well as WHO (Annex 1 presents the full list of participants).

The First General Meeting marked the start of the operational phase of the Network. Participants discussed the expected benefits of the Network for stakeholders and agreed approaches to its operationalization. The importance of involving manufacturers and procurement organizations was highlighted, as they provide the links to the destination, synonym for recipient, countries where redundant testing needs to be addressed. Participants provided feedback about the information-sharing platform and made suggestions on the structure and content of future meetings.

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018